-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UBPNo71i5VWM3NcYQDsSNLs5bAPJptobfN15IFlRdciBmyF3g3oZFhEkRsGw/oaf YlgZrrW2GFdJwlOdKg8+HQ== 0001367982-07-000408.txt : 20071002 0001367982-07-000408.hdr.sgml : 20071002 20071002144953 ACCESSION NUMBER: 0001367982-07-000408 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071001 FILED AS OF DATE: 20071002 DATE AS OF CHANGE: 20071002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOLTERMAN ORVILLE G CENTRAL INDEX KEY: 0001236394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 071149288 BUSINESS ADDRESS: BUSINESS PHONE: 8585522200 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-10-01 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001236394 KOLTERMAN ORVILLE G 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 0 1 0 0 Sr VP Clinical and Regulatory Common Stock 2007-10-01 4 M 0 3300 9.625 A 122830 D Common Stock 2007-10-01 4 S 0 3300 49.7675 D 119530 D Common Stock 2007-10-01 4 M 0 3400 11.125 A 122930 D Common Stock 2007-10-01 4 S 0 3400 49.7675 D 119530 D Non-Qualified Stock Option (right to buy) 9.625 2007-10-01 4 M 0 3300 0 D 2010-11-17 Common Stock 3300 7900 D Non-Qualified Stock Option (right to buy) 11.125 2007-10-01 4 M 0 3400 0 D 2011-03-08 Common Stock 3400 10350 D This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. These options were part of a 5,000 share option grant which fully vested on 11/17/2002. 5,000 options vested on 03/08/2002, and monthly after that, until all the 20,000 options were completely vested on 03/08/2005. By: /s/Lloyd A. Rowland, Attorney-in-Fact For: Orville G. Kolterman 2007-10-02 -----END PRIVACY-ENHANCED MESSAGE-----